# M2I Life Sciences: Biotechnology, Saint Cloud, France

> M2I Life Sciences: M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare...

Source: https://millionrounds.com/startup/m2i-life-sciences-2 (Millionrounds; every figure on the page links to its filing or article)

France · [Biotechnology startup](https://millionrounds.com/companies)

# M2I Life Sciences

M2I Vision: Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological cro

Follow M2I Life Sciences and see its new rounds in your feed. [Sign up free](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fm2i-life-sciences-2)

Funding reported Last round: Debt Financing

Biotechnology Saint Cloud, France

Company summary

- **Founded:** 2012 14 years old
- **Team:** 135 51 to 200 people
- **Funding reported:** 79.2M as listed, currency not stated
- **Last round:** Debt Financing Nov 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for M2I Life Sciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About M2I Life Sciences

M2I Vision: Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological cro

p protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of proprietary DMFs and has already successfully applied its nonconventional retrosynthetic approach of active ingredients, using continuus processing, to solve important quality and stability issues on proprietary APIs. M2I also develops pheromones based solutions for crop protection and veterinary art. M2I works in close partnership with its clients to develop and supply high quality molecules in a cost efficient way.

## What company datasets say M2I Life Sciences raised

Funding, as reported

Reported in all **79.2M** in the source's currency

Last round **Debt Financing**

Last round date **Nov 2020**

## Biotechnology in France

Startups like it

- [**Valneva** Saint-herblain · founded 2013](https://millionrounds.com/startup/valneva)
- [**Abivax** Paris · founded 2013](https://millionrounds.com/startup/abivax)
- [**Amolyt Pharma** Écully · founded 2015](https://millionrounds.com/startup/amolyt-pharma)
- [**GenSight Biologics** Paris · founded 2012](https://millionrounds.com/startup/gensight-biologics)
- [**Novexel** founded 2004](https://millionrounds.com/startup/novexel)
- [**Agronutris** Saint-orens-de-gameville · founded 2011](https://millionrounds.com/startup/agronutris)
- [**Carbios** Clermont-ferrand · founded 2011](https://millionrounds.com/startup/carbios)
- [**Calida Therapeutics** Paris · founded 2022](https://millionrounds.com/startup/calida-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put M2I Life Sciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)